Optimer Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
The company is developing an easy to use platform technology for the rapid assembly of single-chain, straight-branched oligosaccharides--a rational design appproach to carbohydrate drug discovery.
You may also be interested in...
Optimer Fires Execs For Questionable Financial Practices
A year after FDA approval of its antibiotic Dificid, the Optimer board has ousted its chairman and at least two other top executives.
Glycobiology's Second Wave
New technologies to characterize and manipulate carbohydrate chemistries and the glycosylation of proteins are spawning viable business models that address what scientists have long known: the sugar coating of proteins and cells is not decorative.
Glycobiology's Second Wave
New technologies to characterize and manipulate carbohydrate chemistries and the glycosylation of proteins are spawning viable business models that address what scientists have long known: the sugar coating of proteins and cells is not decorative.